Abstract Muscle invasive bladder cancers (BCs) can be divided into 2 major subgroups-basal/squamous (BASQ) tumors and luminal tumors. Since Pparg has low or undetectable expression in BASQ tumors. we tested the effects of rosiglitazone. Pparg agonist. https://diversefinesfoods.shop/product-category/collections/